36/120
1.5 / 5 stars
All 120 Win/Lose results shown below
CSTL Roast Me summary
CASTLE BIOSCIENCES INC (CSTL). Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Win; Revenue growth Win; EPS growth Lose.
Trailing 1 year (4 quarters): 3 wins, 9 lossesLast fetched: 25 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseCSTL / S&P -2.85% / 15.20% |
LoseCSTL / S&P 3.18% / 15.00% |
LoseCSTL / S&P CSTL unavailable / 50.40% |
| 2026-Q10/3 |
LoseCSTL / S&P -36.89% / -4.33% |
LoseCSTL / S&P -2.06% / 11.30% |
LoseCSTL / S&P CSTL unavailable / 27.70% |
| 2025-Q41/3 |
WinCSTL / S&P 70.84% / 2.65% |
LoseCSTL / S&P 3.66% / 9.00% |
LoseCSTL / S&P -233.87% / 13.40% |
| 2025-Q32/3 |
WinCSTL / S&P 11.51% / 8.12% |
WinCSTL / S&P 10.15% / 4.61% |
LoseCSTL / S&P -314.29% / 13.45% |
| 2025-Q21/3 |
LoseCSTL / S&P 2.00% / 10.94% |
WinCSTL / S&P 20.40% / 4.83% |
LoseCSTL / S&P CSTL unavailable / 10.63% |
| 2025-Q11/3 |
LoseCSTL / S&P -24.88% / -4.27% |
WinCSTL / S&P 38.43% / 4.98% |
LoseCSTL / S&P CSTL unavailable / 10.57% |
| 2024-Q41/3 |
LoseCSTL / S&P -6.56% / 2.41% |
WinCSTL / S&P 51.09% / 5.25% |
LoseCSTL / S&P CSTL unavailable / 6.15% |
| 2024-Q32/3 |
WinCSTL / S&P 31.01% / 5.89% |
WinCSTL / S&P 62.43% / 5.89% |
LoseCSTL / S&P CSTL unavailable / 6.11% |
| 2024-Q21/3 |
LoseCSTL / S&P -1.72% / 4.28% |
WinCSTL / S&P 71.67% / 5.38% |
LoseCSTL / S&P CSTL unavailable / 5.12% |
| 2024-Q11/3 |
LoseCSTL / S&P 2.64% / 10.56% |
WinCSTL / S&P 64.71% / 5.71% |
LoseCSTL / S&P CSTL unavailable / 5.59% |
| 2023-Q42/3 |
WinCSTL / S&P 27.77% / 11.69% |
WinCSTL / S&P 60.38% / 6.81% |
LoseCSTL / S&P CSTL unavailable / 7.78% |
| 2023-Q32/3 |
WinCSTL / S&P 23.10% / -3.27% |
WinCSTL / S&P 55.17% / 7.52% |
LoseCSTL / S&P CSTL unavailable / -5.03% |
| 2023-Q21/3 |
LoseCSTL / S&P -39.61% / 8.74% |
WinCSTL / S&P 52.01% / 9.50% |
LoseCSTL / S&P CSTL unavailable / -8.57% |
| 2023-Q11/3 |
LoseCSTL / S&P -3.48% / 7.50% |
WinCSTL / S&P 55.13% / 10.77% |
LoseCSTL / S&P CSTL unavailable / -15.69% |
| 2022-Q41/3 |
LoseCSTL / S&P -9.74% / 7.56% |
WinCSTL / S&P 45.65% / 11.88% |
LoseCSTL / S&P CSTL unavailable / -17.99% |
| 2022-Q32/3 |
WinCSTL / S&P 18.82% / -4.88% |
WinCSTL / S&P 43.31% / 13.47% |
LoseCSTL / S&P CSTL unavailable / -1.41% |
| 2022-Q21/3 |
LoseCSTL / S&P -51.07% / -16.10% |
WinCSTL / S&P 41.13% / 13.71% |
LoseCSTL / S&P CSTL unavailable / 11.04% |
| 2022-Q12/3 |
WinCSTL / S&P 4.64% / -4.60% |
WinCSTL / S&P 44.21% / 15.97% |
LoseCSTL / S&P CSTL unavailable / 42.23% |
| 2021-Q41/3 |
LoseCSTL / S&P -35.53% / 11.03% |
WinCSTL / S&P 50.18% / 15.00% |
LoseCSTL / S&P CSTL unavailable / 96.40% |
| 2021-Q31/3 |
LoseCSTL / S&P -9.31% / 0.58% |
WinCSTL / S&P 37.09% / 10.77% |
LoseCSTL / S&P -788.89% / 69.42% |
| 2021-Q21/3 |
LoseCSTL / S&P 7.11% / 8.55% |
WinCSTL / S&P 24.86% / 6.58% |
LoseCSTL / S&P -317.39% / 51.81% |
| 2021-Q11/3 |
LoseCSTL / S&P 1.95% / 6.17% |
WinCSTL / S&P 12.35% / -1.06% |
LoseCSTL / S&P CSTL unavailable / 7.39% |
| 2020-Q42/3 |
WinCSTL / S&P 30.52% / 12.15% |
WinCSTL / S&P 20.79% / -3.72% |
LoseCSTL / S&P CSTL unavailable / -33.42% |
| 2020-Q32/3 |
WinCSTL / S&P 36.51% / 8.93% |
WinCSTL / S&P 37.92% / -2.04% |
LoseCSTL / S&P CSTL unavailable / -27.10% |
| 2020-Q22/3 |
WinCSTL / S&P 26.43% / 20.54% |
WinCSTL / S&P 80.74% / -0.46% |
LoseCSTL / S&P CSTL unavailable / -27.11% |
| 2020-Q12/3 |
WinCSTL / S&P -13.27% / -19.60% |
WinCSTL / S&P 117.52% / 3.47% |
LoseCSTL / S&P CSTL unavailable / -14.75% |
| 2019-Q42/3 |
WinCSTL / S&P 89.99% / 9.07% |
WinCSTL / S&P 127.62% / 5.36% |
LoseCSTL / S&P CSTL unavailable / 2.99% |
| 2019-Q30/3 |
LoseCSTL / S&P CSTL unavailable / 1.70% |
LoseCSTL / S&P CSTL unavailable / 5.02% |
LoseCSTL / S&P CSTL unavailable / 0.21% |
| 2019-Q20/3 |
LoseCSTL / S&P CSTL unavailable / 4.30% |
LoseCSTL / S&P CSTL unavailable / 6.64% |
LoseCSTL / S&P CSTL unavailable / 8.65% |
| 2019-Q10/3 |
LoseCSTL / S&P CSTL unavailable / 13.65% |
LoseCSTL / S&P CSTL unavailable / 8.12% |
LoseCSTL / S&P CSTL unavailable / 14.29% |
| 2018-Q40/3 |
LoseCSTL / S&P CSTL unavailable / -13.52% |
LoseCSTL / S&P CSTL unavailable / 9.05% |
LoseCSTL / S&P CSTL unavailable / 18.23% |
| 2018-Q30/3 |
LoseCSTL / S&P CSTL unavailable / 7.71% |
LoseCSTL / S&P CSTL unavailable / 10.21% |
LoseCSTL / S&P CSTL unavailable / 19.06% |
| 2018-Q20/3 |
LoseCSTL / S&P CSTL unavailable / 3.43% |
LoseCSTL / S&P CSTL unavailable / 9.03% |
LoseCSTL / S&P CSTL unavailable / 14.46% |
| 2018-Q10/3 |
LoseCSTL / S&P CSTL unavailable / -0.76% |
LoseCSTL / S&P CSTL unavailable / 7.68% |
LoseCSTL / S&P CSTL unavailable / 12.46% |
| 2017-Q40/3 |
LoseCSTL / S&P CSTL unavailable / 6.64% |
LoseCSTL / S&P CSTL unavailable / 7.03% |
LoseCSTL / S&P CSTL unavailable / 13.82% |
| 2017-Q30/3 |
LoseCSTL / S&P CSTL unavailable / 4.48% |
LoseCSTL / S&P CSTL unavailable / 5.68% |
LoseCSTL / S&P CSTL unavailable / 17.57% |
| 2017-Q20/3 |
LoseCSTL / S&P CSTL unavailable / 3.09% |
LoseCSTL / S&P CSTL unavailable / 4.83% |
LoseCSTL / S&P CSTL unavailable / 17.74% |
| 2017-Q10/3 |
LoseCSTL / S&P CSTL unavailable / 6.07% |
LoseCSTL / S&P CSTL unavailable / 3.67% |
LoseCSTL / S&P CSTL unavailable / 13.32% |
| 2016-Q40/3 |
LoseCSTL / S&P CSTL unavailable / 3.82% |
LoseCSTL / S&P CSTL unavailable / 2.09% |
LoseCSTL / S&P CSTL unavailable / 7.05% |
| 2016-Q30/3 |
LoseCSTL / S&P CSTL unavailable / 3.85% |
LoseCSTL / S&P CSTL unavailable / 0.20% |
LoseCSTL / S&P CSTL unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-28
| Metric | CSTL total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 39.65% | 20.78% |
| Annualized return | 39.65% | 20.78% |
5Y · 2021-09-01 to 2026-08-28
| Metric | CSTL total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -55.58% | 83.14% |
| Annualized return | -14.98% | 12.86% |
10Y · 2019-07-25 to 2026-08-28
| Metric | CSTL total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 56.68% | 319.30% |
| Annualized return | 4.59% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-25.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B |